Revised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular Dystrophy by Mercuri, E et al.
RESEARCH ARTICLE
Revised North Star Ambulatory Assessment
for Young Boys with Duchenne Muscular
Dystrophy
Eugenio Mercuri1*, Giorgia Coratti1, Sonia Messina2, Valeria Ricotti3, Giovanni Baranello4,
Adele D’Amico5, Maria Carmela Pera1, Emilio Albamonte1, Serena Sivo1, Elena
Stacy Mazzone1, Maria Teresa Arnoldi4, Lavinia Fanelli1, Roberto De Sanctis1, Domenico
M Romeo1, Gian Luca Vita2, Roberta Battini6, Enrico Bertini5, Francesco Muntoni3,
Marika Pane1
1 Department of Paediatric Neurology, Catholic University, and Nemo Roma center for neuromuscular
disorders, Rome, Italy, 2 Department of Neurosciences and Nemo and Clinical Center, Psychiatry and
Anaesthesiology, University of Messina, Messina, Italy, 3 Dubowitz Neuromuscular Centre, Institute of Child
Health, University College, London, United Kingdom, 4 Developmental Neurology Unit, Istituto Neurologico
“Besta”, Milan, Italy, 5 Unit of Neuromuscular and Neurodegenerative Diseases, Department of
Neurosciences, Bambino Gesù Children's Hospital, Rome, Italy, 6 Department of Developmental
Neuroscience, Stella Maris Institute, Pisa, Italy
*mercuri@rm.unicatt.it
Abstract
The advent of therapeutic approaches for Duchenne muscular dystrophy (DMD) has
highlighted the need to identify reliable outcome measures for young boys with DMD. The
aim of this study was to develop a revised version of the North Star Ambulatory Assessment
(NSAA) suitable for boys between the age of 3 and 5 years by identifying age appropriate
items and revising the scoring system accordingly. Using the scale in 171 controls between
the age of 2.9 and 4.8 years, we identified items that were appropriate at different age
points. An item was defined as age appropriate if it was completed, achieving a full score,
by at least 85% of the typically developing boys at that age. At 3 years (±3months) there
were only 8 items that were age appropriate, at 3 years and 6 months there were 13 items
while by the age of 4 years all 17 items were appropriate. A revised version of the scale was
developed with items ordered according to the age when they could be reliably performed.
The application of the revised version of the scale to data collected in young DMD boys
showed that very few of the DMD boys were able to complete with a full score all the age
appropriate items. In conclusion, our study suggests that a revised version of the NSAA can
be used in boys from the age of 3 years to obtain information on how young DMD boys
acquire new abilities and how this correlates with their peers.
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Introduction
The recent development of therapeutic approaches for Duchenne Muscular Dystrophy (DMD)
has highlighted the need to identify clinical outcome measures for clinical trials [1–3]. So far
most of the trials have focused on boys above the age of 5 years. With the first completed clini-
cal trials showing promising results however there is increasing pressure from advocacy
groups, clinicians, industries and regulatory authorities, to start possible treatments when the
disease is still in the early phase, before muscle tissue becomes progressively replaced.
Little however has been reported on how to assess young DMD boys before the age of 5
years, and more generally on early neurodevelopmental and motor aspects in preschool DMD
boys [4–5]. This is mainly due to the fact that although DMD children already show some
signs of developmental delay and inability to develop new motor abilities by the age of 2 years,
age at diagnosis is still on average above the age of four years.
Only recently, using neurodevelopmental scales (Bayley scale in US and Griffiths scales in
Italy/UK), two studies have provided information on the profile of developmental difficulties
in young DMD boys. These studies showed similar findings. Gross motor and speech delay
were often the presenting signs. With increasing age, DMD boys acquire new skills and
improve the ability to perform some motor activities while other activities, such as running fast
or hopping are not commonly achieved in DMD boys not treated with steroids. Even if boys
acquire new skills, however, when compared to their peers, repeated measures analysis reveal
that gross motor scores, decline over time as they do not approach the gross motor skills
expected for typically developing boys of the same age. Scales like the Bayley however can only
be used up to the age of 36 months and there is therefore a gap between this age and the age of
5 years, when validated measures and natural history data are available [4–5].
There have been suggestions that the North Star Ambulatory Assessment (NSAA), a func-
tional scale specifically developed for assessing motor function in DMD, and validated in
ambulant DMD children older than 5 years, may be used in younger children [6].
In a recent study, we used the NSAA in typically developing preschool boys at different ages
from the age of 3 in order to assess which are the activities that are not consistently achieved at
different age points (3 years, 3.5 years, 4 years etc). The results showed that the scale, in its orig-
inal version including 17 items, could be used from the age of 4 years but that before the age of
4, many items, such as standing on one leg or hopping, were not suitable as these assessed
activities that were not always achieved by typically developing boys at that age [6].
The aim of this study was to develop a revised version of the NSAA suitable for boys
between the age of 3 and 5 years. More specifically we wished to:
i) expand the previous work on typically developing boys in order to better define the items
that are developmentally appropriate before the age of 5 years; ii) develop a revised version
that, at each age, only includes age appropriate items and revise the scoring system accordingly;
iii) apply this scoring system to available NSAA data obtained in young DMD boys.
Subjects and Methods
The study is a prospective multicentric study involving four tertiary neuromuscular centers in
Italy and one in United Kingdom.
The study was approved by the Ethics committee in each center (Catholic University and
Ospedale Bambino Gesù, Rome; University of Messina, Messina; Stella Maris Institute, Pisa;
Neurological Institute C. Besta, Dubowitz Neuromuscular Centre, London). As the assessments
were already part of the clinical routine in all centers, consent to anonymously record the data
in a database was obtained by the parents for the boys under age. For the typically developing
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boys, parents signed an informed consent to participate to the study. Data was collected for
both cohorts between January 2013 and June 2015.
Control group
171 controls between the age of 3 and 5 years were examined in their schools by six examiners
from 3 centers (Rome, Milan, Pisa). Parents and teachers were asked if the child was born pre-
maturely or if there was any previous concern about their development leading to a referral to
a pediatrician or a neurologist. When this occurred, children were assessed but their data were
not included in the analysis. Their age ranged from 2 years, 9 months to 4 years and 8 months.
DMD
173 assessments from 75 DMD boys younger than five years and with a genetically proven
DMD diagnosis were included. As diagnosis was performed often around the age of 4 years,
not all boys had serial longitudinal assessments. In order to make sure that the abilities
achieved were not the result of pharmacological intervention boys on steroids were excluded.
NSAA
The scale is an ordinal scale consisting of 17 items, ranging from standing (item 1) to running
(item 17). It includes several items assessing abilities that are necessary to remain functionally
ambulant, items assessing abilities, such as head raise and standing on heels that can be partly
present in the early stages of the disease and a number of activities such as hopping, or running
that are generally never fully achieved in untreated DMD boys but that have been found in
those treated with daily steroids.
Each item can be scored on a 3 point scale using simple criteria: 2 –Normal achieves goal
without any assistance; 1 –Modified method but achieves goal independent of physical assis-
tance from another person; 0 –Unable to achieve independently.
A total score can be achieved by summing the scores for all the individual items. The score
can range from 0, if all the activities are failed, to 34, if all the activities are achieved.
Details of the training for the physiotherapists involved in the study and of the interobserver
reliability for NSAA among the centers have already been reported [7–11].
Defining age specific items
Data on the NSAA in controls at the age younger than 5 years were already available from our
recent study, but we increased the number in each subgroup, using the same assessors, the
same testing procedures and the same settings used in the previous study [6]. The only differ-
ence in recruitment is that we expanded the lower age level as the youngest group included
boys of age 3 years ± 3 months and excluded those at age 5 years as by this age many boys had
started steroid treatment. The data was analyzed subdividing the cohort into boys assessed at 3,
3.5, 4 and 4.5 years (± 3 months for each subgroup).
A frequency distribution was calculated for each item at each age point, using a cut-off
point of 85%. An item was defined as age appropriate if it was completed, achieving a full
score, by at least 85% of the typically developing boys at that age. The cut-off point of 85% was
arbitrarily chosen among those commonly used as in many tests 15th centile is often used to
define values outside the normal range.
At each age point, only the items considered age appropriate were selected and contributed
to the maximum total score for that age group.
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In order to be sure that our findings in the controls were not discordant with reported devel-
opmental milestones, the results obtained in the control group were compared to a number of
developmental scales, including the Griffiths mental scales, the Denver developmental scales,
Alberta Infant Motor scales [12–14] for which age related reference data were available.
Application of the new scoring system to the DMD data
Cross sectional data were available for 173 assessments from 75 boys who had at least one
assessment before the age of 5 years. At each age point, only the items that had been identified
as age appropriate were selected. The total score achieved was then expressed as % predicted in
relation to the maximum total score achievable at that age.
Statistical analysis
As the DMD and typically developing boys were matched for age (p>0.05) and sex, the com-
parison of the results for each item was assessed by using the Wilcoxon matched pairs signed-
ranks test.
Level of significance was set at p<0.05.
Results
Control group
At age 3, full scores were consistently achieved by 85% of the controls only in 8 items
(1,2,3,6,7,10,14,17) with a maximum age appropriate total score of 16.
At age 3.5 years full scores were achieved by 85% of the controls in 5 additional items
(4,5,8,9,13). The number of age appropriate items increased to 13, with a maximum age appro-
priate total score of 26.
By age 4 years, full scores were achieved in 85% of the controls in all 17 items (including
11,12,15,16) with a maximum age appropriate total score of 34, both at 4 and at 4.5 years.
Table 1 shows details of the frequency distribution for each item in the control group.
The comparison with available developmental scales for which age related reference data
(were available confirmed that the activities in the individual items (12–13) were compatible
with what observed in our study on controls.
On the basis of these results, the scale was designed rearranging the order of the items. The
first part of the revised scale only includes the 8 items that can be administered at 3 years, the
second part includes the additional 5 items that can be assessed at 3.5 years and the final part
the last 4 items that can be assessed after the age of 4 years (Table 2).
DMD cohort
23 patients had an assessment at 3 years, their total scores ranged between 8 and 16 (mean total
score: 11, SD: 2.16). 44 patients had an assessment at 3.5 years, their total scores ranged
between 4 and 25 (mean total score: 16, SD: 3.84); 46 patients had an assessment at 4 years,
their total scores ranged between 6 and 33 (mean total score: 20, SD: 5.96); 60 patients had an
assessment at 4.5 years, their total scores ranged between 10 and 34 (mean total score: 22, SD:
6.09). Details of the scores in the whole cohort are provided in S1 Table. Their mean % pre-
dicted scores went from 69% at 3 years, to 61, 59 and 65% at the subsequent ages.
Fig 1 shows median, and ranges of the scores in DMD compared to the controls.
Revised NSAA for Young DMD
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Table 1. Frequency distribution of controls reaching a full score on individual NSAA items at different age points. The shaded cells indicate the
activities that were achieved by at least 85% of the boys at that age point and were therefore considered as age appropriate.
North Star CONTROLS 3 years (n:35) CONTROLS 3.5 years(n:51) CONTROLS 4 years(n:33) CONTROLS 4.5 years(n:52)
1 Stand Full score: 100% Full score: 100% Full score: 100% Full score: 100%
Mean: 2 Mean: 2 Mean: 2 Mean: 2
St.Dv: 0 St.Dv: 0 St.Dv: 0 St.Dv: 0
2 Walk(10m) Full score: 100% Full score: 100% Full score: 100% Full score: 100%
Mean: 2 Mean: 2 Mean: 2 Mean: 2
St.Dv: 0 St.Dv: 0 St.Dv: 0 St.Dv: 0
3 Sit to stand from chair Full score: 100% Full score: 100% Full score: 100% Full score: 100%
Mean: 2 Mean: 2 Mean: 2 Mean: 2
St.Dv: 0 St.Dv: 0 St.Dv: 0 St.Dv: 0
6 Climb step—R Full score: 86% Full score: 98% Full score: 97% Full score: 98%
Mean: 1.857 Mean: 1.980 Mean: 1.969 Mean: 1.980
St.Dv: 0.355 St.Dv: 0.140 St.Dv: 0.174 St.Dv: 0.138
7 Climb step—L Full score: 86% Full score: 96% Full score: 100% Full score: 100%
Mean: 1.828 Mean: 1.960 Mean: 2 Mean: 2
St.Dv: 0.452 St.Dv: 0.196 St.Dv: 0 St.Dv: 0
10 Gets to sitting Full score: 97% Full score: 100% Full score: 97% Full score: 100%
Mean: 1.971 Mean: 2 Mean: 1.969 Mean: 2
St.Dv: 0.169 St.Dv: 0 St.Dv: 0.174 St.Dv: 0
14 Jump Full score: 94% Full score 96% Full score: 100% Full score: 100%
Mean: 1.914 Mean: 1.960 Mean: 2 Mean: 2
St.Dv: 0.373 St.Dv: 0.196 St.Dv: 0 St.Dv: 0
17 Run Full score: 86% Full score: 88% Full score: 97% Full score: 100%
Mean: 1.882 Mean: 1.882 Mean: 1.969 Mean: 2
St.Dv: 0.327 St.Dv: 0.325 St.Dv: 0.174 St.Dv: 0
4 Stand on one leg—R Full score: 66% Full score: 88% Full score: 97% Full score: 100%
Mean: 1.657 Mean: 1.882 Mean: 1.969 Mean: 2
St.Dv: 0.481 St.Dv: 0.325 St.Dv: 0.174 St.Dv: 0
5 Stand on one leg—L Full score: 69% Full score: 86% Full score: 97% Full score: 100%
Mean: 1.685 Mean: 1.862 Mean: 1.969 Mean: 2
St.Dv: 0.471 St.Dv: 0.347 St.Dv: 0.174 St.Dv: 0
8 Descend step—R Full score: 74% Full score 94% Full score: 100% Full score 98%
Mean: 1.714 Mean: 1.941 Mean: 2 Mean: 1.980
St.Dv: 0.518 St.Dv: 0.237 St.Dv: 0 St.Dv: 0.138
9 Descend step—L Full score: 63% Full score: 88% Full score: 94% Full score: 100%
Mean: 1.514 Mean: 1.862 Mean: 1.909 Mean: 2
St.Dv: 0.701 St.Dv: 0.401 St.Dv: 0.384 St.Dv: 0
13 Stand on heels Full score: 77% Full score: 90% Full score: 91% Full score: 92%
Mean: 1.742 Mean: 1.901 Mean: 1.909 Mean: 1.923
St.Dv: 0.505 St.Dv: 0.300 St.Dv: 0.291 St.Dv: 0.269
11 Rise from ﬂoor Full score: 40% Full score 65% Full score 97% Full score: 92%
Mean: 1.400 Mean: 1.647 Mean: 1.969 Mean: 1.923
St.Dv: 0.497 St.Dv: 0.483 St.Dv: 0.174 St.Dv: 0.269
12 Lifts head Full score: 43% Full score: 75% Full score: 88% Full score: 92%
Mean: 1.382 Mean: 1.745 Mean: 1.878 Mean: 1.923
St.Dv: 0.603 St.Dv: 0.440 St.Dv: 0.331 St.Dv: 0.269
(Continued)
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Comparison between typically developing and DMD boys
When we compared the individual items and the total score in each age subgroup in typically
developing versus DMD boys (Tables 1 and 2), we found that DMD boys showed significantly
lower scores compared to their age matched controls in the total score and in the individual
items, with the exception of items 1, 2, 3, 9 and 12 in the 3 year group and items 1, and 2 in the
other subgroups.
Discussion
Over the last few years there has been increasing concern about the possibility to find reliable
outcome measures in young DMD. The few published studies have demonstrated that motor
activities and, more generally motor development, can be measured, but a number of issues
should be taken into account. Developmental scales provide the opportunity to follow longitu-
dinally young boys and to obtain developmental quotients using age appropriate reference data
at each age point [15–16]. The problem with these scales is that they include a wide range of
items that are not always relevant to DMD and can only be used up to a certain age. In contrast,
functional motor scales, like the NSAA are not appropriate for children below the age of 4 and
have only been validated for boys above the age of 5. Other scales, like the MFM have also been
validated from the age of 5 years [17].
In order to fill this gap, we adapted the NSAA to make it suitable for boys younger than 5
years. We first assessed all the NSAA 17 items in a cohort of typically developing children of
age between 3 years and 4.5 years (+3 months), subdivided according to their age age at 6
month intervals. At each age point, we included only the items that were age appropriate, as
they could be completed by more than 85% of the controls, excluding the others. This resulted
in a scale including only 8 items for boys at 3 years, 13 items at 3.5 while, by the age of 4 all the
original items could be included. The appropriateness of the items selected at each age point
was confirmed looking at the age reference of the same activities on different neurodevelop-
mental assessments.
The revised version combines the advantages of the neurodevelopmental scales, allowing to
assess the level of function in relation to age, with the properties of the original NSAA scale.
Unlike neurodevelopmental scales, that include a range of activities that are not specific to
DMD, the NSAA scale items were specifically selected to assess activities reflecting the pattern
of muscle weakness found in DMD. Furthermore, the scoring system allows to score not only if
the boys are able to perform a task (score 2) but also if the task can be achieved using other
Table 1. (Continued)
North Star CONTROLS 3 years (n:35) CONTROLS 3.5 years(n:51) CONTROLS 4 years(n:33) CONTROLS 4.5 years(n:52)
15 Hop—R Full score: 23% Full score: 67% Full score: 88% Full score: 88%
Mean: 1.057 Mean: 1.588 Mean: 1.878 Mean: 1.884
St.Dv: 0.639 St.Dv: 0.638 St.Dv: 0.331 St.Dv: 0.322
16 Hop—L Full score: 14% Full score: 69% Full score: 88% Full score: 90%
Mean: 0.857 Mean: 1.627 Mean: 1.878 Mean: 1.903
St.Dv: 0.648 St.Dv: 0.598 St.Dv: 0.331 St.Dv: 0.297
TOT Mean: 28.371 Mean: 31.843 Mean: 33.303 Mean: 33.519
St.Dv: 3.581 St.Dv: 2.318 St.Dv: 1.015 St.Dv: 0.851
Max: 34 Max: 34 Max: 34 Max: 34
Min: 20 Min: 25 Min: 31 Min: 31
doi:10.1371/journal.pone.0160195.t001
Revised NSAA for Young DMD
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strategies (score 1), that is very common in DMD and allows better chances to observe possible
changes following intervention.
Another advantage of the revised version compared to neurodevelopmental scales is that
while those can be used only in the first years, the NSAA, in its revised version, can be used
from the age of 3 years until they lose ambulation.
The application of the revised version of the scale to our retrospective DMD data confirmed
that young DMD boys often acquire the ability to perform new abilities with increasing age but
only few of the DMD boys, at any age, achieve a full total score for their age. Our cross sectional
Table 2. Revised version of the NSAAwith items ordered according to the age when they can be performed.
ACTIVITY 2 1 0
1 Stand Stands upright, still and symmetrically,
without compensation (with heels ﬂat and
legs in neutral) for minimum count of 3 secs
Stands still but with some degree of
compensation (e.g. on toes or with legs
abducted or with bottom stuck out) for minimum
count of 3 secs
Cannot stand still or independently,
needs support (even minimal)
2 Walk Walks with heel-toe or ﬂat-footed gait pattern Persistent or habitual toe walker, unable to heel-
toe consistently
Loss of independent ambulation—




Keeping arms folded. Starting position 90o
hips and knees, feet on ﬂoor/supported on a
box step.






Faces step—no support needed Goes up sideways or needs support Unable
7 Climb
box step- Left
Faces step—no support needed Goes up sideways or needs support Unable
10 Gets to
sitting
Starts in supine—may use one hand to assist Self assistance e.g.–pulls on legs or uses head-
on- hands or head ﬂexed to ﬂoor
Unable
14 Jump Both feet at the same time, clear the ground
simultaneously
One foot after the other (skip) Unable
17 Run Both feet off the ground (no double stance
phase during running)
‘Duchenne jog’ Unable
TOTAL 3 years (max score 16)
4 Stand on one
leg—Right
Able to stand in a relaxed manner (no
ﬁxation) for count of 3 seconds
Stands but either momentarily or needs a lot of
ﬁxation e.g. by knees tightly adducted or other
trick
Unable
5 Stand on one
leg—Left
Able to stand in a relaxed manner (no
ﬁxation) for count of 3 seconds
Stands but either momentarily or needs a lot of





Faces forward, climbs down controlling
weight bearing leg. No support needed
Sideways, skips down or needs support Unable
9 Descend box
—Left
Faces forward, climbs down controlling
weight bearing leg. No support needed
Sideways, skips down or needs support Unable
13 Stands on
heels
Both feet at the same time, clearly standing
on heels only (acceptable to move a few
steps to keep balance) for count of 3
Flexes hip and only raises forefoot Unable
TOTAL 3.5years (max score 26)
11 Rise from
ﬂoor
From supine—no evidence of Gowers’
manoeuvre*
Gowers’ evident (a) NEEDS to use external support
object e.g. chair OR (b) Unable
12 Lifts head In supine, head must be lifted in mid-line.
Chin moves towards chest
Head is lifted but through side ﬂexion or with no
neck ﬂexion
15 Hop—Right Clears forefoot and heel off ﬂoor Clears forefoot and heel off ﬂoor Unable
16 Hop—Left Clears forefoot and heel off ﬂoor Clears forefoot and heel off ﬂoor Unable
TOTAL 4 years and above (max score 34)
doi:10.1371/journal.pone.0160195.t002
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study show how the raw scores were progressively higher in boys from the age of 3 to 4.5 years.
At 4 years the scores were higher than at 3 and 3.5 but the score adjusted for age, using % pre-
dicted, were lower with increasing age as they do not achieve the skills gained by typically
developing boys of the same age. After the age of 4, both the raw and % predicted scores
appeared to be higher than that found in younger boys. Although these findings should be
interpreted with caution as this was not a longitudinal study, they appear to confirm longitudi-
nal data obtained using the Bayley scales in boys between the age of 2 and 3 years suggesting
that in the early phases of development DMD boys acquire many activities but with a delay [5].
Interestingly, the activities that showed improvement, suggesting a possible delay, were climb-
ing or descending steps while others, such as hopping or running fast, could not be achieved
even at the age of 4 or 4.5 years. This is not surprising as in DMD these are generally only
achieved in boys on steroids and these were not included in this paper.
In conclusion, our study suggests that a revised version of the NSAA can be used in boys
from the age of 3 years to assess early functional changes and obtain information on how
young DMD boys acquire new abilities with increasing age and how this correlates with their
peers. Further studies, using longitudinal data will help to better understand the range of
changes and to identify possible changes related to type and site of mutations or to the use of
steroids or other interventions that are increasingly used in boys younger than 4 years. Further
studies, collecting larger datasets, will also help to establish if the revised scale maintains the
psychometric properties of the full NSAA demonstrated by Rasch analysis.
Supporting Information
S1 Table. DMD boys on individual NSAA items at different age points. The shaded cells
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